Showing results (381-390 of 395) with videos related to

Sort By:
Pageof 40
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2003
Implementation of proficiency testing in conjunction with a rechecking system for external quality assurance in tuberculosis laboratories in MexicoA Martinez-Guarneros, S Balandrano-Campos, M A Solano-Ceh, et al.
The Pediatric Infectious Disease Journal|September 1, 1995
High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky communityJ S Duchin, R F Breiman, A Diamond, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1993
Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study GroupB N Doebbeling, D L Breneman, H C Neu, et al.
Diagnostic Microbiology and Infectious Disease|February 11, 1992
Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistanceH C Neu, R J Duma, R N Jones, et al.
Archives of Internal Medicine|August 12, 1996
Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease GroupW L Straus, J F Plouffe, T M File, et al.
Archives of Internal Medicine|August 11, 1997
Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study GroupB J Marston, J F Plouffe, T M File, et al.
International Journal of Epidemiology|May 26, 1999
A community outbreak of Legionnaires' disease linked to hospital cooling towers: an epidemiological method to calculate dose of exposureC M Brown, P J Nuorti, R F Breiman, et al.
Blood|November 1, 1995
Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicityZ P Bernstein, M M Porter, M Gould, et al.
Transfusion|January 3, 2001
Laboratory performance in HTLV-I/II analysisL O Williams, S O Blumer, W O Schalla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnessesR L Moolenaar, C Dalton, H B Lipman, et al.
Pageof 40